HPV Vaccine Shows Promising Results
Human papillomavirus (HPV) is a sexually-transmitted infection that newly affects approximately three million people in the United States every year. Currently, the Centers for Disease Control and Prevention (CDC) estimate that as many as one out of every four Americans may be infected with HPV. HPV is among the leading causes of cervical cancer for women; and, while treatment options are available, there is currently no known cure.
Since the first HPV vaccine received FDA approval in 2006, vaccination has proven to be an effective method for reducing the risk of HPV. In fact, a recent report indicates that the three approved HPV vaccines – Gardasil, Gardasil 9 and Cervarix – may be working even better than originally anticipated.
HPV Vaccines Linked to 50 Percent Decline in Cervical Cancer Rate
According to a study published in the journal, JAMA Oncology, and as reported by CBS News, ten years after its release the HPV vaccine appears to be doing its job effectively. Abnormal cell growth and pre-cancers are down by approximately 50 percent – an amount that is “greater than expected” according to lead researcher Cosette Wheeler, a professor at the University of New Mexico.
As more children and adults are vaccinated against HPV, not only are vaccine recipients less likely to contract the disease, but so-called “herd immunity” is decreasing the risk for those who choose not to get immunized. The study also suggests that one or two doses may be enough to effectively immunize vaccine recipients against HPV.
CDC Still Recommends Three Doses of the HPV Vaccine
Despite these positive results, it should be noted that HPV remains prevalent in the United States, and the CDC still recommends that everyone up to a certain age (with only limited exceptions for individuals with certain allergies and other health risks) get vaccinated against HPV. The standard course of immunization includes three doses, administered over a six-month period. The CDC recommends that boys and girls be immunized at age 11 or 12, prior to becoming exposed to the virus. The HPV vaccine is generally considered safe for females and males through age 26.
What to Do If You Experience a Reaction to the HPV Vaccine
Despite its effectiveness in preventing disease, like all vaccines, the HPV vaccine is not risk-free. The risk of experiencing a severe allergic reaction is one concern, as is the risk of a shoulder injury related to vaccine administration (SIRVA). Both types of injuries can make vaccine recipients eligible for compensation under the federal government’s National Vaccine Injury Compensation Program (VICP), and if you or someone you love has experienced an HPV vaccine injury it is important that you speak with a lawyer right away.
Learn more about your rights under the National Vaccine Injury Compensation Program (VICP).
No-Cost Legal Representation for HPV Vaccine Injury Claims
The Law Offices of Leah V. Durant & Associates is a national law firm that provides no-cost legal representation to individuals and families whose children have experienced vaccine-related injuries. To speak with an experienced attorney about your rights, call (202) 775-9200 or schedule an appointment for your free consultation today.